Efficacy and safety of neoadjuvant chemotherapy (NACT) with paclitaxel plus carboplatin and oral metronomic chemotherapy (OMCT) in patients with technically unresectable oral squamous cell carcinoma (OSCC)

A combination of maximum tolerated dose and metronomic chemotherapy schedule may lead to synergistic effects with acceptable toxicity. We assessed the efficacy and safety of this combination as neoadjuvant chemotherapy (NACT) in 14 patients with technically unresectable oral squamous cell carcinoma....

Descripción completa

Detalles Bibliográficos
Autores principales: Kashyap1, Lakhan, Patil, Vijay, Noronha, Vanita, Joshi, Amit, Menon, Nandini, Jobanputra, Kunal, Saha, Saswata, Chaturvedi, Pankaj, Banavali, Shripad D, Prabhash, Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8816505/
https://www.ncbi.nlm.nih.gov/pubmed/35211194
http://dx.doi.org/10.3332/ecancer.2021.1325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8816505/
https://www.ncbi.nlm.nih.gov/pubmed/35211194
http://dx.doi.org/10.3332/ecancer.2021.1325

Ejemplares similares